ArticleFrontiers in cardiovascular medicine2025

Factors influencing the selection of an SGLT2i vs. a GLP-1RA as cardioprotective agent in patients with type 2 diabetes.

Shubham Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.